DEMCON LIFE SCIENCES & HEALTH ENSCHEDE BV

Dypha: adding the dimension of time to cell culture

Operating in european innovation council based in Enschede, DEMCON LIFE SCIENCES & HEALTH ENSCHEDE BV operates.

Profile

The current preclinical drug development pipeline is highly inefficient with 9 out of 10 drugs failing when first tested in humans. Of those failures, between 69% and 81% is due to a lack of efficacy (52-57%) or safety (17-24%), indicating that the predictivity of currently used cell culture and animal models is not high enough. While promising human cell culture models have arisen in the last decades (e.g. pluripotent stem cell models, spheroids, organoids), the environment of these models is too simplistic to reach their full potential and to translate certain responses to humans.

One of the important aspects missing in current cell culture is kinetics: many processes in the human body have response times with resolutions of seconds, minutes or hours. In standard cell culture however, such temporal resolution is absent because cell culture medium remains unchanged for typically 1-3 days. So for kinetics, scientists turn to animal models with relatively low translational success and high costs.

As an alternative, complex microfluidic setups have been used to enable perfusion in vitro and demonstrated a significant amount of evidence that kinetics can improve the relevance of cell culture models. Despite the evidence, typical cell culture biologists are not taking kinetics into account because the tools to control kinetics in cell culture are too complex.

We solve this pro

Its activity falls under european innovation council; the profile below is assembled from public directory data.

Its base of operations is Enschede.

It is recorded at the SIGNED stage.

Website: www.demcon.nl